Cargando…
Compliance with The RSV Immunoprophylaxis Dosing Schedule in The Polish Registry for Palivizumab (2008-2014)
BACKGROUND: Respiratory syncytial virus infection causes respiratory diseases in about 90% of the children under 2 years of age. Currently the only way to prevent infection is through immunoprophylaxis based on palivizumab. AIM: The aim of the study was to assess compliance with the recommended prop...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sciendo
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522825/ https://www.ncbi.nlm.nih.gov/pubmed/30636227 http://dx.doi.org/10.34763/devperiodmed.20182204.308314 |